History of acute promyelocytic leukemia: a tale of endless revolution.
作者信息
Lo-Coco Francesco, Cicconi Laura
机构信息
Department of Biopathology, Tor Vergata University, Rome, Italy.
出版信息
Mediterr J Hematol Infect Dis. 2011;3(1):e2011067. doi: 10.4084/MJHID.2011.067. Epub 2011 Dec 21.
Abstract
摘要
相似文献
1
History of acute promyelocytic leukemia: a tale of endless revolution.急性早幼粒细胞白血病的历史：一部无尽革命的故事。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011067. doi: 10.4084/MJHID.2011.067. Epub 2011 Dec 21.
2
[Retinoids and acute promyelocytic leukemia. A therapeutic revolution].[维甲酸与急性早幼粒细胞白血病。一场治疗革命]
Rev Med Liege. 1996 Mar;51(3):217-23.
3
Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia.急性早幼粒细胞白血病诊断与治疗的分子基础
Rev Bras Hematol Hemoter. 2012;34(2):134-9. doi: 10.5581/1516-8484.20120033.
4
Mouse models of acute promyelocytic leukemia.急性早幼粒细胞白血病的小鼠模型
Curr Opin Hematol. 2001 Jul;8(4):206-11. doi: 10.1097/00062752-200107000-00005.
5
Survival and treatment response in adults with acute promyelocytic leukemia treated with a modified International Consortium on Acute Promyelocytic Leukemia protocol.采用改良的国际急性早幼粒细胞白血病联合会方案治疗的成人急性早幼粒细胞白血病患者的生存情况及治疗反应
Rev Bras Hematol Hemoter. 2016 Oct-Dec;38(4):285-290. doi: 10.1016/j.bjhh.2016.08.002. Epub 2016 Sep 21.
6
Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.急性早幼粒细胞白血病患者中三氧化二砷治疗效果的抑制因素。
Chin Med J (Engl). 2014;127(19):3503-6.
7
Acute promyelocytic leukemia with increased bone marrow reticulin fibrosis: Description of three cases and review of the literature.伴有骨髓网硬蛋白纤维化增加的急性早幼粒细胞白血病：三例病例描述及文献复习
Hematol Oncol Stem Cell Ther. 2018 Jun;11(2):99-104. doi: 10.1016/j.hemonc.2016.08.001. Epub 2016 Sep 2.
8
Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study.成人急性早幼粒细胞白血病患者的分子复发和血液学复发：一项队列研究
Rev Bras Hematol Hemoter. 2017 Jan-Mar;39(1):46-51. doi: 10.1016/j.bjhh.2016.09.010. Epub 2016 Oct 21.
9
Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.小鼠急性早幼粒细胞白血病细胞的表达谱分析揭示了多种模型依赖性进展特征。
Mol Cell Biol. 2004 Dec;24(24):10882-93. doi: 10.1128/MCB.24.24.10882-10893.2004.
10
Chromosomal abnormality of acute promyelocytic leukemia other than -: a case report of acute promyelocytic leukemia with del(5q).除-之外的急性早幼粒细胞白血病染色体异常：一例伴有5号染色体长臂缺失的急性早幼粒细胞白血病病例报告
BMC Clin Pathol. 2016 Oct 4;16:16. doi: 10.1186/s12907-016-0038-4. eCollection 2016.
引用本文的文献
1
MPO Expression of Background Neutrophils in MPO Negative Acute Promyelocytic Leukemia, An Easy Clue to Corroborate a Challenging Diagnosis: A Case Report and Review of Literature.MPO阴性急性早幼粒细胞白血病中背景中性粒细胞的MPO表达：确诊疑难诊断的简易线索——病例报告及文献复习
Case Rep Hematol. 2023 Dec 26;2023:7979261. doi: 10.1155/2023/7979261. eCollection 2023.
2
Rapid detection of myeloid neoplasm fusions using single-molecule long-read sequencing.使用单分子长读长测序技术快速检测髓系肿瘤融合基因
PLOS Glob Public Health. 2023 Sep 12;3(9):e0002267. doi: 10.1371/journal.pgph.0002267. eCollection 2023.
3
Coagulation Abnormalities and Risk Assessment in Acute Promyelocytic Leukemia: An Experience From a Resource-Constraint Country.急性早幼粒细胞白血病的凝血异常与风险评估：来自资源受限国家的经验
Cureus. 2022 Jun 17;14(6):e26026. doi: 10.7759/cureus.26026. eCollection 2022 Jun.
4
A Rare Case of Acute Pericarditis as a Primary Presentation of Differentiation Syndrome.一例以分化综合征为主要表现的急性心包炎罕见病例。
Cureus. 2022 Apr 17;14(4):e24213. doi: 10.7759/cureus.24213. eCollection 2022 Apr.
5
The Integration of a Hospitalist.一名住院医师的融入
Glob Adv Health Med. 2022 Feb 15;11:21649561211073879. doi: 10.1177/21649561211073879. eCollection 2022.
6
Acute promyelocytic leukemia (APL): a review of the literature.急性早幼粒细胞白血病（APL）：文献综述
Oncotarget. 2020 Mar 17;11(11):992-1003. doi: 10.18632/oncotarget.27513.
7
Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model.杂环二脒 DNA 配体作为 HOXA9 转录因子抑制剂：在依赖 HOXA9 的白血病细胞模型中的设计、分子评估和细胞后果。
J Med Chem. 2019 Feb 14;62(3):1306-1329. doi: 10.1021/acs.jmedchem.8b01448. Epub 2019 Feb 1.
8
Arsenic trioxide: insights into its evolution to an anticancer agent.三氧化二砷：抗癌药物的发展历程。
J Biol Inorg Chem. 2018 May;23(3):313-329. doi: 10.1007/s00775-018-1537-9. Epub 2018 Feb 2.
9
NLS‑RARα modulates acute promyelocytic leukemia NB4 cell proliferation and differentiation via the PI3K/AKT pathway.核定位信号-维甲酸受体α通过PI3K/AKT信号通路调节急性早幼粒细胞白血病NB4细胞的增殖和分化。
Mol Med Rep. 2016 Dec;14(6):5495-5500. doi: 10.3892/mmr.2016.5932. Epub 2016 Nov 8.
10
NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.核定位信号-维甲酸受体α通过与p38α丝裂原活化蛋白激酶相互作用抑制全反式维甲酸对NB4细胞的作用。
Int J Med Sci. 2016 Jul 18;13(8):611-9. doi: 10.7150/ijms.15374. eCollection 2016.
本文引用的文献
1
Treatment advances have not improved the early death rate in acute promyelocytic leukemia.治疗进展并未改善急性早幼粒细胞白血病的早期死亡率。
Haematologica. 2012 Jan;97(1):133-6. doi: 10.3324/haematol.2011.046490. Epub 2011 Oct 11.
2
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.尽管采用全反式维甲酸治疗，但急性早幼粒细胞白血病的早期死亡率仍然很高。
Blood. 2011 Aug 4;118(5):1248-54. doi: 10.1182/blood-2011-04-346437. Epub 2011 Jun 8.
3
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.急性早幼粒细胞白血病的持续高早期死亡率：来自瑞典成人急性白血病登记处的一项基于人群的报告。
Leukemia. 2011 Jul;25(7):1128-34. doi: 10.1038/leu.2011.78. Epub 2011 Apr 19.
4
Modern approaches to treating acute promyelocytic leukemia.现代治疗急性早幼粒细胞白血病的方法。
J Clin Oncol. 2011 Feb 10;29(5):495-503. doi: 10.1200/JCO.2010.32.1067. Epub 2011 Jan 10.
5
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.三氧化二砷可改善急性早幼粒细胞白血病成人患者的无事件生存和总生存：北美白血病协作组研究 C9710。
Blood. 2010 Nov 11;116(19):3751-7. doi: 10.1182/blood-2010-02-269621. Epub 2010 Aug 12.
6
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.AIDA 诱导后适应风险的巩固治疗用于年龄小于 61 岁的成人急性早幼粒细胞白血病的一线治疗：意大利血液与骨髓移植组 AIDA-2000 试验的结果。
Blood. 2010 Oct 28;116(17):3171-9. doi: 10.1182/blood-2010-03-276196. Epub 2010 Jul 19.
7
Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.前瞻性微小残留病监测以预测急性早幼粒细胞白血病的复发并指导先发制性三氧化二砷治疗。
J Clin Oncol. 2009 Aug 1;27(22):3650-8. doi: 10.1200/JCO.2008.20.1533. Epub 2009 Jun 8.
8
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia.全反式维甲酸/三氧化二砷疗法在新诊断急性早幼粒细胞白血病中的长期疗效与安全性
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3342-7. doi: 10.1073/pnas.0813280106. Epub 2009 Feb 18.
9
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.全反式维甲酸和蒽环类单药化疗对急性早幼粒细胞白血病的风险适应性治疗：PETHEMA 组 LPA 99 多中心研究的长期结果
Blood. 2008 Oct 15;112(8):3130-4. doi: 10.1182/blood-2008-05-159632. Epub 2008 Jul 29.
10
Acute promyelocytic leukemia: from highly fatal to highly curable.急性早幼粒细胞白血病：从高度致命到高度可治愈。
Blood. 2008 Mar 1;111(5):2505-15. doi: 10.1182/blood-2007-07-102798.
Zotero 插件